Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis

被引：2
|
作者：
Battistelli, Cecilia [1 ]
Diederich, Marc [2 ]
Keane, Timothy Joseph [3 ]
Sandoval, Pilar [4 ]
Valente, Sergio [5 ]
Strippoli, Raffaele [1 ,6 ]
机构：
[1] Sapienza Univ Rome, Dept Mol Med, Rome, Italy
[2] Seoul Natl Univ, Dept Pharm, Seoul, South Korea
[3] Imperial Coll London, Dept Mat, London, England
[4] UAM, CSIC, Severo Ochoa Mol Biol Ctr, Madrid, Spain
[5] Sapienza Univ Rome, Dept Chem & Technol Drugs, Rome, Italy
[6] Natl Inst Infect Dis L Spallanzani IRCCS, Rome, Italy
来源：
FRONTIERS IN PHARMACOLOGY | 2020年 / 10卷
关键词：
natural compound; EMT; fibrosis; epigenetics; non-coding RNAs; therapeutic targets;
D O I：
10.3389/fphar.2019.01556
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Epithelial to Mesenchymal Transition in Neuroblastoma: Mechanisms and Therapeutic Considerations
    Leila Jahangiri
    Current Tissue Microenvironment Reports, 2024, 5 (4): : 91 - 108
  • [22] EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) IN CHOLANGIOCYTES DOES NOT CONTRIBUTE TO LIVER FIBROSIS
    Scholten, David
    Scholten, Anjali
    Brenner, David A.
    Kisseleva, Tatiana
    HEPATOLOGY, 2009, 50 (04) : 818A - 818A
  • [23] The pathogenic role of Epithelial-mesenchymal transition (EMT) in the fibrosis of diabetic retinopathy
    Zhou, Ti
    Che, Di
    Ma, Jianxing
    Gao, Guoquan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [24] Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic Fibrosis
    Tennakoon, Anusha H.
    Izawa, Takeshi
    Kuwamura, Mitsuru
    Yamate, Jyoji
    JOURNAL OF CLINICAL MEDICINE, 2016, 5 (01)
  • [25] Epithelial-mesenchymal Transition (EMT) Molecular Biomarkers in Malignant IPMN
    Lahat, G. J.
    Lowenstein, S.
    Nachmany, I.
    Benhaim, M.
    Nakache, R.
    Santo, I.
    Inbar, M.
    Halperin, Z.
    Klausner, J. M.
    Lubezky, N.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S9 - S9
  • [26] Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic Strategies
    Sui, Hua
    Zhu, Lei
    Deng, Wanli
    Li, Qi
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (10) : 584 - 589
  • [27] Ovarian fibrosis: molecular mechanisms and potential therapeutic targets
    Gu, Mengqing
    Wang, Yibo
    Yu, Yang
    JOURNAL OF OVARIAN RESEARCH, 2024, 17 (01)
  • [28] Mechanisms of microRNA Regulation of the Epithelial-Mesenchymal Transition (EMT) in Lung Cancer
    Martinez-Espinosa, Israel
    Serrato, Jose A.
    Cabello-Gutierrez, Carlos
    Carlos-Reyes, Angeles
    Ortiz-Quintero, Blanca
    LIFE-BASEL, 2024, 14 (11):
  • [29] Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition
    Pi, Peng
    Zeng, Zhipeng
    Zeng, Liqing
    Han, Bing
    Bai, Xizhe
    Xu, Shousheng
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [30] Molecular mechanisms of epithelial to mesenchymal transition in tumor metastasis
    Nieszporek, Artur
    Skrzypek, Klaudia
    Adamek, Grazyna
    Majka, Marcin
    ACTA BIOCHIMICA POLONICA, 2019, 66 (04) : 509 - 520
12345